Health Care Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7% 3 years ago Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite… Zoetis Inc (ZTS) Q1 2023 Earnings Call Transcript 3 years ago Zoetis Inc (NYSE:ZTS) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Steve Frank -- Vice President of Investor… Ironwood Pharmaceuticals, Inc (IRWD) Q1 2023 Earnings Call Transcript 3 years ago Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Matt Roache -- Director, Investor Relations… Key highlights from Moderna’s (MRNA) Q1 2023 earnings results 3 years ago Moderna, Inc. (NASDAQ: MRNA) reported first quarter 2023 earnings results today. Total revenue was $1.9 billion, compared to $6.1 billion… Regeneron Pharmaceuticals Inc (REGN) Q1 2023 Earnings Call Transcript 3 years ago Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations… Becton, Dickinson and Company (BDX) Q2 2023 Earnings Call Transcript 3 years ago Becton, Dickinson and Company (NYSE:BDX) Q2 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Francesca DeMartino -- Senior Vice… CVS Health Corp. (CVS) Q1 2023 Earnings: Key financials and quarterly highlights 3 years ago CVS Health Corporation (NYSE: CVS) reported first quarter 2023 earnings results today. Total revenues increased 11% year-over-year to $85.3 billion.… Pfizer inc (PFE) Q1 2023 Earnings Call Transcript 3 years ago Pfizer inc (NYSE:PFE) Q1 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Christopher Stevo -- Senior Vice President, Investor Relations… Corcept Therapeutics Incorporated (CORT) Q1 2023 Earnings Call Transcript 3 years ago Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Atabak Mokari -- Chief Financial… Sage Therapeutics Inc (SAGE) Q1 2023 Earnings Call Transcript 3 years ago Sage Therapeutics Inc (NASDAQ:SAGE) Q1 2023 Earnings Call dated May. 02, 2023. Corporate Participants: Helen Rubinstein -- Director of Investor Relations Barry… Next» « Previous